Br. Karlsson et al., DEXMEDETOMIDINE, A POTENT ALPHA(2)-AGONIST, DOES NOT AFFECT NEURONAL DAMAGE FOLLOWING SEVERE FOREBRAIN ISCHEMIA IN THE RAT, European journal of anaesthesiology, 12(3), 1995, pp. 281-285
Central sympathetic activation with increased release of noradrenaline
occurs during cerebral ischaemia, but it is not certain how the incre
ased sympathetic activity affects neuronal damage. We have studied the
effect of dexmedetomidine, a potent alpha(2)-adrenergic receptor agon
ist that reduces the central release of noradrenaline, on neuronal dam
age after 10 min of severe forebrain ischaemia in the rat. Ischaemia w
as achieved by bilateral carotid artery occlusion combined with bleedi
ng to a mean arterial pressure of 50 mmHg. The post-ischaemic neuronal
damage was most pronounced in the hippocampal CA1 region (median perc
entage of necrotic cells 36% (11-69%) and 42% (11-68%) in the dexmedet
omidine and vehicle groups, respectively) and in the subiculum. The re
ticular thalamic nucleus was moderately damaged in all but one rat, wh
ile the rest of the thalamus was almost spared. Most rats had mild to
moderate damage in cortex and caudoputamen. Dexmedetomidine did not af
fect the neuronal outcome in this model.